<DOC>
	<DOCNO>NCT02305043</DOCNO>
	<brief_summary>The aim study identify biomarkers predict response resistance factor target therapy trastuzumab advance gastric cancer .</brief_summary>
	<brief_title>Identification Biomarkers Prediction Response Resistance Against Target Therapy Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>histologically proven adenocarcinoma stomach gastroesophageal junction stage IV patient receive chemotherapy sign informed consent Age &gt; 18 year Patient understand mean purpose study patient already receive chemotherapy treatment advance disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>non-interventional</keyword>
	<keyword>advanced gastric cancer</keyword>
	<keyword>Trastuzumab</keyword>
	<keyword>HER2</keyword>
</DOC>